Question 1

What is the catalog number for GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued?

Accepted Answer

The catalog number for GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued is 036245-APC.

Question 2

What sizes are available for GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued?

Accepted Answer

GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued is available in the following size(s): 200 µL.

Question 3

Is GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued in stock?

Accepted Answer

GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

GPR50, ID (GPR50, Melatonin-related receptor, G protein-coupled receptor 50, H9) (APC) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-FENS1/WDFY1 Antibody Picoband®, FITC Conjugate

Pgp9.5 (UCHL-1) (13C4), CF568 conjugate, 0.1mg/mL

Eosinophil Peroxidase (AHE-1), 0.2mg/mL

Cyclin A1 (XLA1-3), CF405S conjugate, 0.1mg/mL

VEGF-R2 / CD309 / Flk-1 / KDR3 (DC101), 1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL